" /> DC-OVA Vaccine - CISMeF





Preferred Label : DC-OVA Vaccine;

NCIt definition : An autologous, multivalent dendritic cell vaccine targeting ovarian cancer with potential immunostimulating and antineoplastic activities. DC-OVA vaccine is produced in vitro by pulsing autologous dendritic cells with killed autologous primary ovarian tumors as a source of tumor-associated antigens (TAAs); the pulsed DCs are then matured using various cytokines. Upon administration, DC-OVA vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against ovarian cancer TAA-expressing ovarian cancer cells.;

NCI Metathesaurus CUI : CL376121;

Details


You can consult :


Nous contacter.
02/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.